“As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as Zika, Ebola and dengue fever, have grown into major global health epidemics with great human and economic toll. Today, IBM Research (NYSE: IBM) and Singapore’s Institute of Bioengineering, Nanotechnology (IBN) announced they have identified a new breakthrough macromolecule that could help prevent deadly virus infections with a unique triple-play mechanism that can also help prevent viral drug resistance.”
Related Content
Related Posts:
- IBM Lab-on-a-Chip Breakthrough Aims to Help Physicians Detect Cancer and Diseases at the Nanoscale
- How governments and companies should advance trusted AI
- IBM and NASA Open Source Largest Geospatial AI Foundation Model on Hugging Face
- IBM Quantum Computer Demonstrates Next Step Towards Moving Beyond Classical Supercomputing
- T-Systems to Offer Quantum Computing Expertise and Access to IBM Quantum Computational Resources
- IBM, Vodafone, and GSMA Members Outline Critical Pathways to Protect Telcos Against Quantum-Era Cyberthreats
- IBM and Rapidus Form Strategic Partnership to Build Advanced Semiconductor Technology and Ecosystem in Japan
- IBM and Vodafone Join Forces in Exploration of Quantum Computing Technology and Quantum-Safe Cryptography
- IBM Unveils 400 Qubit-Plus Quantum Processor and Next-Generation IBM Quantum System Two
- Cleveland Clinic and IBM Begin Installation of IBM Quantum System One